Calliditas Therapeutics AB (publ) (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price
on Sep 20, 2024
CALT Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CALT stock had an average target of 39.25, with a low estimate of 39 and a high estimate of 40.
Analyst Consensus: Hold
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for CALT stock from 4 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | -2.50% | May 31, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $58 → $39 | Strong Buy → Hold | Downgrades | $58 → $39 | -2.50% | May 28, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $55 → $40 | Strong Buy → Hold | Downgrades | $55 → $40 | -0.00% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $39 | Strong Buy → Hold | Downgrades | $39 | -2.50% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +12.50% | May 24, 2024 |
Financial Forecast
Revenue This Year
2.01B
from 1.21B
Increased by 66.54%
Revenue Next Year
3.28B
from 2.01B
Increased by 62.94%
EPS This Year
2.34
from -8.69
EPS Next Year
19.20
from 2.34
Increased by 719.41%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.5B | 4.7B | 7.6B | ||
| Avg | 2.0B | 3.3B | 4.7B | ||
| Low | 1.8B | 2.6B | 3.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.6% | 136.2% | 133.1% | ||
| Avg | 66.5% | 62.9% | 42.8% | ||
| Low | 46.9% | 29.5% | -5.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.85 | 46.83 | 98.39 | ||
| Avg | 2.34 | 19.20 | 40.08 | ||
| Low | -1.34 | 9.45 | 16.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,898.5% | 412.4% | ||
| Avg | - | 719.4% | 108.7% | ||
| Low | - | 303.2% | -15.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.